
z21 Ventures is a community-driven early-stage venture capital fund partnering with technology founders at the pre-seed and seed stage across the India-US corridor, focusing on AI and deep tech. Backed by a 205+ member community of operators and executives, it provides proprietary deal flow and go-to-market support to portfolio companies.
Deal activity increased 50% year-over-year (3 deals in the last 12 months). Their most common stage is seed (50% of deals). Average disclosed round size is $8.6M (across 16 rounds with reported amounts).
Portfolio
12
Fund Size
$40M
Top Stage
Seed
Last 12 Mo
3
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
18 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Series A | — | Jan 2026 | |
| RRisa Labs | Series A | $11.1M | Jan 2026 |
| HHen Technologies | Series A | $20M | Dec 2025 |
| Seed | $3.5M | Apr 2025 | |
| TThe Energy Company | Series A | $2M | Feb 2025 |
| TThe Energy Company | Series A | $2M | Jan 2025 |
| Series A | $40M | Jan 2024 | |
| Seed | — | Nov 2023 | |
| Seed | $2.4M | — | |
| Seed | $2M | — | |
| Seed | $3.5M | — | |
| Unknown | $14M | — | |
| Seed | $19M | — | |
| Seed | $1.2M | — | |
| RRisa Labs | Seed | $3.5M | — |
| HHen Technologies | Seed | $8M | — |
| HHen Technologies | Grant | $1M | — |
| Unknown | $4.8M | — |
Top Co-Investors
Oncology Ventures5 shared
General Catalyst3 shared
Optum Ventures3 shared
Cencora Ventures2 shared
3one4 Capital2 shared
BEENEXT2 shared
LVX2 shared
Silicon Valley Bank1 shared
CaaS Capital1 shared
Struck Capital1 shared
Rebright Partners1 shared
468 Capital1 shared
Y Combinator1 shared
DG Daiwa Ventures1 shared
Blueprint Equity1 shared
Bienville Capital1 shared
Jigsaw1 shared
Creandum1 shared
Repeat Ventures1 shared
MD One Ventures1 shared
Last updated: 20 October 2026